Institute of Biotechnology
of the Czech Academy of Sciences

The team from the Laboratory of Molecular Pathogenetics, led by Gabriela Pavlínková from the Institute of Biotechnology of the Czech Academy of Sciences at the BIOCEV center, played a significant role in international research, the results of which were published in the prestigious journal Nature Communications. The study provides new insights that contribute to the development of cell therapy for diabetes.

In April, the 4th IBT Student Day took place at the BIOCEV campus. The conference, organized by PhD students of the Institute of Biotechnology of the Czech Academy of Sciences, offered a full-day program of scientific presentations and discussions.

From the Institute of Biotechnology to the U.S. and back. After three years at Emory University in Atlanta, Maroš Huličiak returned to the institute where he once began his career. Thanks to his newly acquired experience, he took on the role of head of the Centre of Molecular Structure. What did he bring back from his time abroad, where does he want to take the CMS, and what is it like to return “home”?

The Institute of Biotechnology of the Czech Academy of Sciences hosted the first event of the Women in Science @ IBT (WiSe@IBT) initiative, which aims to foster open discussion on topics related to careers and the workplace.

Governor Petra Pecková and members of the Regional Council presented the 2025 Governor’s Awards. This traditional award recognises individuals who are closely connected to the Central Bohemian Region and contribute to its development. A total of 58 outstanding personalities from seven different areas of public life were nominated this year.

Professor Jiří Neužil from the Institute of Biotechnology of the Czech Academy of Sciences has received the Distinguished Collaborative Research Fellow Award from the Malaghan Institute of Medical Research in New Zealand.

How can qPCR be used correctly and common pitfalls avoided? A new study co-authored by researchers from the Institute of Biotechnology of the Czech Academy of Sciences offers practical guidance for more accurate and reliable analysis.

In the early stages of Alzheimer’s disease, changes occur in a key protein called tau, which normally forms a protective layer around the neuron’s internal skeleton. When modified, tau loses its protective function, leading to neuron death. The new perspective presented by a Czech-French research team uncovers the molecular consequences of tau modifications, opening new avenues for the diagnosis and treatment of early-stage Alzheimer’s disease and related disorders.

The Czech startup Carta Genum received a pre-seed investment of €40,000 from the Czech Founders VC fund to develop a platform for spatial biology. The project, led by scientists Lukáš Valihrach and Daniel Žucha from the Institute of Biotechnology of the Czech Academy of Sciences, is leading to the development of virtual bioinformatics—a tool that will enable biologists to analyze large and complex scientific data without the need for programming.

The government's decision to cut funding for research and development comes at a time when the share of public spending on science has been declining for a long time. According to Eurostat data, total R&D expenditure in the European Union is around 2.24% of GDP, while the Czech Republic continues to invest less (around 1.8–2% of GDP), which places it below the EU average and confirms the need to strengthen stable funding for science.